Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM
· Real-Time Price · USD
19.19
1.05 (5.79%)
At close: Aug 21, 2025, 11:27 AM
Quantum BioPharma Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 362.92K | 499.7K | 490K | 502.8K | 526.93K | 1.51M | 2.52M | 3.56M | 4.49M | 4.49M | 4.48M | 4.42M | 4.34M | 4.19M | 4.03M | 3.92M | 3.88M | 3.49M |
Gross Profit | -362.92K | -362.92K | -233.62K | -120.81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -570.69K |
Operating Income | -18.65M | -17.25M | -16.14M | -11.7M | -10.28M | -15.65M | -22.76M | -27.62M | -32.11M | -31.15M | -27.43M | -26.88M | -24.76M | -29.58M | -33.74M | -33.82M | -40.99M | -33.13M |
Interest Income | 453.69K | 467.38K | 572.89K | 594.61K | 604.81K | 686.55K | 786.36K | 932.59K | 824.02K | 640.08K | 367.74K | 67.72K | 2.22K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -27.95M | -21.54M | -14.92M | -11.11M | -8.23M | -10.36M | -18.23M | -22.73M | -28.73M | -31.2M | -26.7M | -26.72M | -25.2M | -29.99M | -33.94M | -31.91M | -38.7M | -29.87M |
Net Income | -26.99M | -20.85M | -14.2M | -10.17M | -7.4M | -9.78M | -17.83M | -22.66M | -28.73M | -27.66M | -23.61M | -23.81M | -22.47M | -31.25M | -35.29M | -33.51M | -41.28M | -32.57M |
Selling & General & Admin | 10.73M | 8.94M | 9.31M | 9.43M | 8.9M | 9.21M | 13.1M | 14.09M | 15.65M | 17.73M | 15.73M | 17.09M | 17.08M | 20.35M | 23.37M | 21.86M | 25.6M | 19.78M |
Research & Development | 7.22M | 7.57M | 6.08M | 1.77M | 994.29K | 1.73M | 3.88M | 6.61M | 8.4M | 8.17M | 6.79M | 4.95M | 3.08M | 5.26M | 6.3M | 7.94M | 11.56M | 9.54M |
Other Expenses | 81.03K | 122.53K | 122.53K | 144.51K | 803.43K | 5.16M | 6.83M | 7.97M | 8.46M | 5.61M | 4.78M | 3.63M | 3.48M | 1.86M | 1.96M | 3.01M | 3.67M | 4.08M |
Operating Expenses | 18.03M | 16.63M | 15.51M | 11.33M | 10.69M | 16.07M | 22.18M | 26.02M | 29.97M | 29M | 26.41M | 25.78M | 23.66M | 27.52M | 31.68M | 32.86M | 40.89M | 33.4M |
Interest Expense | 611.93K | 384.72K | 47.58K | 31.15K | 20.78K | 12.43K | 679.00 | 802.00 | 16.85K | 33.11K | 48.82K | 77.89K | 63.8K | 66.46K | 69.4K | 74.57K | 133.59K | 183.15K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 18.3M | 16.9M | 15.78M | 11.59M | 10.83M | 16.2M | 23.79M | 28.65M | 32.59M | 31.62M | 27.43M | 26.89M | 24.77M | 29.59M | 33.74M | 33.82M | 16.38M | 8.52M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.02M | 1.14M | 1.03M | 917.85K | 641.16K | 610.03K | 606.01K | 602.96K | 603.6K | 599.42K | 597.65K | 587.78K | 591.99K | 615.37K | 576.49K | 558.4K | 553.72K | 413.83K |
Shares Outstanding (Diluted) | 3.02M | 1.14M | 1.03M | 917.85K | 641.16K | 610.03K | 606.01K | 602.96K | 603.6K | 599.42K | 597.65K | 587.78K | 591.99K | 615.37K | 576.49K | 558.4K | 553.72K | 413.83K |
EPS (Basic) | -20.14 | -21.76 | -17.36 | -14.32 | -11.91 | -16.16 | -29.65 | -37.76 | -48.13 | -46.5 | -39.49 | -40.21 | -38.45 | -54.83 | -69.25 | -73.49 | -132.69 | -141.1 |
EPS (Diluted) | -20.14 | -21.76 | -17.36 | -14.32 | -11.91 | -16.16 | -29.65 | -37.76 | -48.13 | -46.5 | -39.49 | -40.21 | -38.45 | -54.83 | -69.25 | -73.49 | -132.69 | -141.1 |
EBITDA | -26.84M | -20.65M | -14.37M | -10.57M | -9.34M | -10.52M | -17.39M | -20.86M | -24.17M | -26.61M | -22.12M | -22.15M | -20.79M | -25.73M | -29.89M | -27.89M | -34.66M | -25.7M |
EBIT | -27.34M | -21.15M | -14.87M | -11.08M | -9.87M | -12.02M | -19.9M | -24.4M | -28.71M | -31.17M | -26.65M | -26.64M | -25.14M | -29.93M | -33.87M | -31.83M | -38.56M | -29.68M |
Depreciation & Amortization | 505.27K | 500.7K | 491.54K | 504.33K | 529.36K | 1.5M | 2.51M | 3.54M | 4.54M | 4.57M | 4.54M | 4.49M | 4.35M | 4.2M | 4.05M | 3.93M | 3.89M | 3.9M |